Literature DB >> 30689251

Meta-analysis comparing outcomes of different transoral surgical modalities in management of oropharyngeal carcinoma.

Ahmed S Ibrahim1,2, Francisco J Civantos2, Jason M Leibowitz2, Giovana R Thomas2, David J Arnold2, Elizabeth J Franzmann2, Elizabeth A Nicolli2, Kaming Lo3, Zsuzsanna Nemeth4, Zoukaa B Sargi2, Donald T Weed2.   

Abstract

BACKGROUND: Optimal transoral surgical modality for oropharyneal carcinoma is currently unclear. Transoral laser surgery (TLS), transoral robotic surgery (TORS), and conventional direct transoral (DT) oropharyngectomy are the main current transoral surgical modalities for oropharyngeal carcinoma.
METHODS: MEDLINE was systematically searched through PubMed. Reference lists were reviewed. Random-effects models were used to combine studies within each group. Tests for heterogeneity were used to explore difference in effect size between groups in subgroup analysis.
RESULTS: Nine studies (404 patients) in TORS arm, five studies (498 patients) in TLS arm, and three studies (335 patients) in DT arm were included. Early T classification (T1-T2) for TORS and DT were higher compared to TLS group (P < .001). There was no significant difference between groups in the rate of invaded margin, post-operative oropharyngeal bleeding, temporary tracheotomy, and gastrostomy dependence.
CONCLUSION: The available data do not yet provide clear evidence of superiority of any one modality.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  TORS; direct transoral oropharyngectomy; oropharyngeal carcinoma; transoral laser surgery; transoral robotic surgery

Mesh:

Year:  2019        PMID: 30689251     DOI: 10.1002/hed.25647

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Endoscopic video-assisted transoral (EVAT) surgery of the oropharynx: clinical, oncological and functional outcomes.

Authors:  Richard Jackson; Elizabeth Ross; Jemy Jose
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-17       Impact factor: 2.503

2.  Second primary squamous cell carcinomas treated with trans oral robotic surgery: Oncological and functional results.

Authors:  Federico Soldati; Karma Lambercy; Christian Simon
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-05-05

Review 3.  Current Role of Surgery in the Management of Oropharyngeal Cancer.

Authors:  Wojciech Golusiński; Ewelina Golusińska-Kardach
Journal:  Front Oncol       Date:  2019-05-24       Impact factor: 6.244

Review 4.  Novel Energy Devices in Head and Neck Robotic Surgery - A Narrative Review.

Authors:  Talisa Ross; Neil S Tolley; Zaid Awad
Journal:  Robot Surg       Date:  2020-04-23

5.  Evaluating the role of the self-assembling topical haemostat PuraBond® in Transoral Robotic Surgery (TORS) for oropharyngeal cancer: A case series.

Authors:  Keshav Kumar Gupta; Georgios Garas; Matthew Idle; Susan Germain; Mriganka De
Journal:  Ann Med Surg (Lond)       Date:  2022-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.